Lyra Therapeutics Inc. (LYRA)
Market Closed
16 Jun, 20:00
OTC PINK OTC PINK Primary $
0. 65
+0.1
+18.1818%
$
781.13K Market Cap
- P/E Ratio
- Div Yield
2,305 Volume
-1.01 Eps
$ 0.55
Previous Close Want to track LYRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lyra Therapeutics Inc. (LYRA) Statistics
Valuation metrics
Market Cap 781.13K
Enterprise value 15.15M
Trailing P/E (ttm) -0.24
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 1.96
Price/Book (mrq) -0.64
Enterprise Value/Revenue 38.06
Enterprise Value/EBITDA -0.55
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 21.48K
Average volume (90 days) 35.95K
Price summary
52-Week low 0.31
52-Week high 14.88
Beta -
50-Day moving average 0.72
200-Day moving average 1.64
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:50
Last split Date 28 May 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -72.66%
Operating margin -77.94%
Operational effectiveness
Return on assets -0.8%
Return on equity 12.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.86
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.02
Total debt (mrq) -
Total Debt/Equity (mrq) -2.82
Current ratio (mrq) 1.71%
Book value per share (mrq) -0.69
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
